Obesity Medicine for the PCP
From June 2019, Does My Liver Look Fat?When an international expert in obesity medicine is (a) a fun, great teacher and (b) happy to talk to Hippo about how we can help our patients lose weight effectively, we jump at the chance to interview her. In this segment, Dr. Kim Gudzune from Johns Hopkins University School of Medicine reviews …
23min 48Kimberly Gudzune, MD MPH and Neda Frayha, MD
Adrenal Incidentaloma
From April 2019, A Maelstrom of Mail!What do you do when you find an adrenal incidentaloma? In this mini-segment, Neda asks endocrinologist and adrenal gland aficionado Dr. Kashif Munir how we should approach the adrenal incidentaloma.
8min 32Neda Frayha, MD and Kashif Munir, MD
Thyroid Nodules and Cancer
From May 2018, The Buzz That Won't QuitThanks to all the imaging studies we order on our patients, we are finding more and more thyroid nodules - and, as a result, diagnosing more thyroid cancer. In this segment, Elizabeth Lamos discusses the evaluation and management of both incidental thyroid nodules and thyroid cancers for the busy …
24min 1Elizabeth Lamos, MD and Neda Frayha, MD
Lifestyle and Diabetes - Part 2
From April 2018, Will You Be My Facebook Friend?In part 2 of this segment on lifestyle and diabetes,Neil and Heidi review yet more evidence pointing toward the effectiveness of weight management and exercise in preventing and managing DM2. As a bonus, Neil concludes his story of how exercise has changed his life and health.
17min 43Heidi James, MD and Neil Skolnik, MD
Paper Chase #3 - ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes
From March 2018, What’s Your (Code) Status?ACE inhibitors and statins did not change the albumin to creatinine ratio over time in this study population.
2min 54Andrew Buelt, DO and Joe Weatherly, DO
Grave’s Disease - Part 2
From January 2018, A Feverish Frenzy!Treatment of Graves disease varies depending on patient characteristics and available options. Methimazole is generally preferred over prophylthiouracil (PTU) though PTU is the drug of choice in the first trimester of pregnancy. Radioiodine ablation may be considered in patients who fail or have …
14min 51Tania Gallant, MD and Heidi James, MD
Paperchase #2 - Liraglutide and Renal Outcomes in Type 2 Diabetes
From December 2017, Jingle, JingleThis study looks at the secondary endpoints of the LEADER trial to find the renal benefit to taking Liraglutide in type 2 diabetic patients. Compared to placebo, this GLP-1 resulted in lower rates of progression to chronic kidney disease. •
5min 4Andrew Buelt, DO and Joe Weatherly, DO
Graves Disease Pt. 1
From December 2017, Jingle, JingleGraves disease is an autoimmune condition and is the most common cause of hyperthyroidism. If suspected based on clinical presentation and history, diagnosis is made by checking TSH (which will be low) and T3/T4 (which will be elevated) and ordering appropriate thyroid imaging, which may including …
11minTania Gallant, MD and Heidi James, MD
Hypercalcemia
From November 2017, Lytes and BitesHypercalcemia is a relatively common electrolyte abnormality and is usually attributable to hyperparathyroidism. Be sure to order an albumin level to help caculate the ionized calcium and rule out a false positive. If Calcium remains elevated on repeat testing, order a PTH level. If the PTH level …
13min 38Heidi James, MD and Malcolm Thaler, MD
Paper Chase 2 - SWITCH 1 Trial
From September 2017, You Can Do It!!The SWITCH 1 trial compared rates of hypoglycemia in patients with Type 1 DM taking either insulin degludec and or insulin glargine U100. While degludec treatment was associated with fewer instances of hypoglycemia than glargine, as it was also the case in patients with DM 2, Joe and Andrew do not …
2min 50Andrew Buelt, DO and Joe Weatherly, DO
Paperchase 1 - The SWITCH 2 Trial
From September 2017, You Can Do It!!The SWITCH 2 trial compared rates of hypoglycemia in patients with Type 2 DM taking either insulin degludec and or insulin glargine U100. While degludec treatment was associated with fewer instances of hypoglycemia, Joe and Andrew do not feel it is clinically significant. •
8min 3Andrew Buelt, DO and Joe Weatherly, DO
Addison’s
From July 2017, Be Kind and Enjoy LifeNeda and endocrinologist Kashif Munir tell us when to suspect and how to diagnose Addison’s disease. From presentation to complications, they bring us all the pearls. •
14min 11Neda Frayha, MD
Paper Chase 4 - Frequency of Retinopathy Screening in Type 1 Diabetes
From July 2017, Be Kind and Enjoy LifeFinally! An evidence based screening guideline for retinopathy in type 1 diabetes that will save a ton of money AND catch advanced disease sooner.
5min 11Andrew Buelt, DO and Joe Weatherly, DO
Resistant Hypertension
From January 2017, Bones Lose Their AutonomyRob and Malcolm Thaler discuss evaluation and management of patients with resistant and secondary hypertension. •
14min 59Malcolm Thaler, MD and Rob Orman, MD
Paper Chase 2: Thyroid Function and Sudden Cardiac Death
From December 2016, Ear Pain is but a MemoryHigher Free T4 levels were associated with increasing risk of sudden cardiac death.
6min 5Andrew Buelt, DO and Joe Weatherly, DO
Hypothyroidism, Part 1
From July 2016, Creme de la ThyroidEndocrinologist Tanya Gallant gives the endocrinologist's perspective on diagnosing and treating hypothyroidism.
19min 30Heidi James, MD and Tania Gallant, MD
Hypothyroidism Part 2
From July 2016, Creme de la ThyroidEndocrinologist Tanya Gallant gives the endocrinologist's perspective on diagnosing and treating hypothyroidism.
15min 27Heidi James, MD and Tania Gallant, MD
Short Stature
From January 2016, Palliative Cerumen EmergenciesShort stature is a common complaint for the general pediatrician. Dr Ben-Isaac defines and reviews the 4 main causes and features of short stature (genetic, familial, constitutional, and pathological), and discusses the indications for growth hormone therapy. •
30min 1Eyal Ben-Isaac, MD and Solomon Behar, MD